{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:16:12Z","timestamp":1778786172681,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"China Academy of Chinese Medicine Sciences","award":["XYZX0404-10"],"award-info":[{"award-number":["XYZX0404-10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-024-02375-8","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T03:54:34Z","timestamp":1732766074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Temporal changes in lipid concentrations and the prevalence of dyslipidemia among individuals with diabetes, prediabetes, and normal blood glucose from 2011 to 2015"],"prefix":"10.1186","volume":"23","author":[{"given":"Mengjie","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wantong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"2375_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271\u201381.","journal-title":"Diabetes Res Clin Pract"},{"key":"2375_CR2","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, Pavkov ME, Ramachandaran A, Wild SH, James S, Herman WH, Zhang P, Bommer C, Kuo S, Boyko EJ, Magliano DJ. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"2375_CR3","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jama.2013.168118","volume":"310","author":"Y Xu","year":"2013","unstructured":"Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, Xu M, Li Y, Hu N, Li J, Mi S, Chen CS, Li G, Mu Y, Zhao J, Kong L, Chen J, Lai S, Wang W, Zhao W, Ning G. 2010 China Noncommunicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948\u201359.","journal-title":"JAMA"},{"issue":"2","key":"2375_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"F Cosentino","year":"2020","unstructured":"Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, Huikuri HV, Johansson I, J\u00fcni P, Lettino M, Marx N, Mellbin LG, \u00d6stgren CJ, Rocca B, Roffi M, Sattar N, Seferovi\u0107 PM, Sousa-Uva M, Valensi P, Wheeler DC, ESC Scientific Document Group. 2019 ESC guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255\u2013323.","journal-title":"Eur Heart J"},{"issue":"8","key":"2375_CR5","first-page":"559","volume":"32","author":"PK Song","year":"2019","unstructured":"Song PK, Man QQ, Li H, Pang SJ, Jia SS, Li YQ, He L, Zhao WH, Zhang J. Trends in Lipids Level and dyslipidemia among Chinese adults, 2002\u20132015. Biomed Environ Sci. 2019;32(8):559\u201370.","journal-title":"Biomed Environ Sci"},{"key":"2375_CR6","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12889-016-2874-7","volume":"16","author":"M Liu","year":"2016","unstructured":"Liu M, Wang J, He Y, Jiang B, Wu L, Wang Y, Di Z, Zeng J. Awareness, treatment and control of type 2 diabetes among Chinese elderly and its changing trend for past decade. BMC Public Health. 2016;16:278.","journal-title":"BMC Public Health"},{"issue":"9","key":"2375_CR7","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jama.2013.168118","volume":"310","author":"Y Xu","year":"2013","unstructured":"Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, Xu M, Li Y, Hu N, Li J, Mi S, Chen CS, Li G, Mu Y, Zhao J, Kong L, Chen J, Lai S, Wang W, Zhao W, Ning G. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948\u201359.","journal-title":"JAMA"},{"issue":"2","key":"2375_CR8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.diabres.2008.04.008","volume":"81","author":"D Hu","year":"2008","unstructured":"Hu D, Fu P, Xie J, Chen CS, Yu D, Whelton PK, He J, Gu D. Increasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults: the InterASIA study. Diabetes Res Clin Pract. 2008;81(2):250\u20137.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2375_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61\u20138.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"2375_CR10","first-page":"390","volume":"35","author":"Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults","year":"2007","unstructured":"Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin xue guan bing za zhi. 2007;35(5):390\u2013419.","journal-title":"Zhonghua Xin xue guan bing za zhi"},{"issue":"8","key":"2375_CR11","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/aje\/kwm402","volume":"167","author":"MA Allison","year":"2008","unstructured":"Allison MA, Budoff MJ, Wong ND, Blumenthal RS, Schreiner PJ, Criqui MH. Prevalence of and risk factors for subclinical cardiovascular disease in selected US hispanic ethnic groups: the multiethnic study of atherosclerosis. Am J Epidemiol. 2008;167(8):962\u20139.","journal-title":"Am J Epidemiol"},{"issue":"33","key":"2375_CR12","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"issue":"4","key":"2375_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","volume":"61","author":"A Varbo","year":"2013","unstructured":"Varbo A, Benn M, Tybjaerg-Hansen A, Jorgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol. 2013;61(4):427\u201336.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2375_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.arcmed.2019.08.009","volume":"50","author":"JC Fern\u00e1ndez-Mac\u00edas","year":"2019","unstructured":"Fern\u00e1ndez-Mac\u00edas JC, Ochoa-Mart\u00ednez AC, Varela-Silva JA, P\u00e9rez-Maldonado IN. Atherogenic index of plasma: Novel Predictive Biomarker for Cardiovascular illnesses. Arch Med Res. 2019;50(5):285\u201394.","journal-title":"Arch Med Res"},{"key":"2375_CR15","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2009.1619","volume":"302","author":"AE Di","year":"2009","unstructured":"Di AE, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302:1993\u20132000.","journal-title":"JAMA"},{"key":"2375_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.959247","volume":"4","author":"AD Sniderman","year":"2011","unstructured":"Sniderman AD, Williams K, Contois JH, Monroe HM, McQueen MJ, De GJ, Furberg CD. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes. 2011;4:337\u201345.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"24","key":"2375_CR17","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1001\/jama.2021.22208","volume":"326","author":"L Wang","year":"2021","unstructured":"Wang L, Peng W, Zhao Z, Zhang M, Shi Z, Song Z, Zhang X, Li C, Huang Z, Sun X, Wang L, Zhou M, Wu J, Wang Y. Prevalence and treatment of diabetes in China, 2013\u20132018. JAMA. 2021;326(24):2498\u2013506.","journal-title":"JAMA"},{"issue":"3","key":"2375_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.diabet.2018.08.008","volume":"45","author":"M Liu","year":"2019","unstructured":"Liu M, Liu SW, Wang LJ, Bai YM, Zeng XY, Guo HB, Liu YN, Jiang YY, Dong WL, He GX, Zhou MG, Yu SC. Burden of diabetes, hyperglycaemia in China from to 2016: findings from the 1990 to 2016, global burden of disease study. Diabetes Metab. 2019;45(3):286\u201393.","journal-title":"Diabetes Metab"},{"issue":"4","key":"2375_CR19","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/jamacardio.2019.0295","volume":"4","author":"S Liu","year":"2019","unstructured":"Liu S, Li Y, Zeng X, Wang H, Yin P, Wang L, Liu Y, Liu J, Qi J, Ran S, Yang S, Zhou M. Burden of Cardiovascular diseases in China, 1990\u20132016: findings from the 2016 global burden of Disease Study. JAMA Cardiol. 2019;4(4):342\u201352.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"2375_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12933-024-02359-z","volume":"23","author":"M Qin","year":"2024","unstructured":"Qin M, Chen B. Association of atherogenic index of plasma with cardiovascular disease mortality and all-cause mortality in the general US adult population: results from NHANES 2005\u20132018. Cardiovasc Diabetol. 2024;23(1):255.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2375_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12933-024-02330-y","volume":"23","author":"Y Sun","year":"2024","unstructured":"Sun Y, Li F, Zhou Y, Liu A, Lin X, Zou Z, Lv X, Zhou J, Li Z, Wu X, Dou S, Zhang M, Zhu J, Chen Y, Xiao X, Hu Y, Li H, Li Y. Nonlinear association between atherogenic index of plasma and type 2 diabetes mellitus in overweight and obesity patients: evidence from Chinese medical examination data. Cardiovasc Diabetol. 2024;23(1):226.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2375_CR22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12933-022-01667-6","volume":"21","author":"JH Huh","year":"2022","unstructured":"Huh JH, Han KD, Cho YK, Roh E, Kang JG, Lee SJ, Ihm SH. Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study. Cardiovasc Diabetol. 2022;21(1):228.","journal-title":"Cardiovasc Diabetol"},{"key":"2375_CR23","doi-asserted-by":"publisher","first-page":"1330650","DOI":"10.3389\/fendo.2024.1330650","volume":"15","author":"R Guo","year":"2024","unstructured":"Guo R, Wei L, Cao Y, Zhao W. Normal triglyceride concentration and the risk of diabetes mellitus type 2 in the general population of China. Front Endocrinol (Lausanne). 2024;15:1330650.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2375_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/jama.298.3.299","volume":"298","author":"BG Nordestgaard","year":"2007","unstructured":"Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death. JAMA. 2007;298(3):299\u2013308.","journal-title":"JAMA"},{"issue":"11","key":"2375_CR25","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/ng.2795","volume":"45","author":"R Do","year":"2013","unstructured":"Do R, Willer CJ, Schmidt EM, Sengupta S, Gao C, Peloso GM, Gustafsson S, Kanoni S, Ganna A, Chen J, Buchkovich ML, Mora S, Beckmann JS, Bragg-Gresham JL, Chang HY, Demirkan A, Den Hertog HM, Donnelly LA, Ehret GB, Esko T, Feitosa MF, Ferreira T, Fischer K, Fontanillas P, et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet. 2013;45(11):1345\u201352.","journal-title":"Nat Genet"},{"issue":"5","key":"2375_CR26","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1373\/clinchem.2013.219881","volume":"60","author":"M Thomsen","year":"2014","unstructured":"Thomsen M, Varbo A, Tybj\u00e6rg-Hansen A, Nordestgaard BG. Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study. Clin Chem. 2014;60(5):737\u201346.","journal-title":"Clin Chem"},{"issue":"1","key":"2375_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12967-019-02156-3","volume":"17","author":"J Zhao","year":"2019","unstructured":"Zhao J, Zhang Y, Wei F, Song J, Cao Z, Chen C, et al. Triglyceride is an independent predictor of type 2 diabetes among middle-aged and older adults. J Transl Med. 2019;17(1):403.","journal-title":"J Transl Med"},{"issue":"5","key":"2375_CR28","doi-asserted-by":"publisher","first-page":"e042821","DOI":"10.1136\/bmjopen-2020-042821","volume":"11","author":"J Peng","year":"2021","unstructured":"Peng J, Zhao F, Yang X, Pan X, Xin J, Wu M, et al. Association between dyslipidemia and risk of type 2 diabetes mellitus in middle-aged and older Chinese adults. BMJ Open. 2021;11(5):e042821.","journal-title":"BMJ Open"},{"issue":"1","key":"2375_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12944-023-01873-5","volume":"22","author":"J Li","year":"2023","unstructured":"Li J, Shi L, Zhao G, Sun F, Nie Z, Ge Z, Gao B, Yang Y. High triglyceride levels increase the risk of diabetic microvascular complications. Lipids Health Dis. 2023;22(1):109.","journal-title":"Lipids Health Dis"},{"issue":"11","key":"2375_CR30","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.3390\/nu14112321","volume":"14","author":"J Zhu","year":"2022","unstructured":"Zhu J, Zhang Y, Wu Y, Xiang Y, Tong X, Yu Y, Qiu Y, Cui S, Zhao Q, Wang N, Jiang Y, Zhao G. Obesity and Dyslipidemia in Chinese adults: a cross-sectional study in Shanghai, China. Nutrients. 2022;14(11):2321.","journal-title":"Nutrients"},{"issue":"4","key":"2375_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11886-021-01455-w","volume":"23","author":"E Bahiru","year":"2021","unstructured":"Bahiru E, Hsiao R, Phillipson D, Watson KE. Mechanisms and treatment of Dyslipidemia in Diabetes. Curr Cardiol Rep. 2021;23(4):26.","journal-title":"Curr Cardiol Rep"},{"issue":"11","key":"2375_CR32","doi-asserted-by":"publisher","first-page":"9084","DOI":"10.3390\/cimb45110570","volume":"45","author":"M Veskovi\u0107","year":"2023","unstructured":"Veskovi\u0107 M, \u0160utulovi\u0107 N, Hrn\u010di\u0107 D, Stanojlovi\u0107 O, Macut D, Mladenovi\u0107 D. The interconnection between hepatic insulin resistance and metabolic dysfunction-associated steatotic liver disease. Curr Issues Mol Biol. 2023;45(11):9084\u2013102.","journal-title":"Curr Issues Mol Biol"},{"key":"2375_CR33","doi-asserted-by":"publisher","first-page":"907973","DOI":"10.3389\/fendo.2022.907973","volume":"13","author":"B Song","year":"2022","unstructured":"Song B, Zhao X, Yao T, Lu W, Zhang H, Liu T, et al. Triglyceride glucose-body mass index and risk of incident type 2 diabetes mellitus. Front Endocrinol. 2022;13:907973.","journal-title":"Front Endocrinol"},{"key":"2375_CR34","doi-asserted-by":"publisher","first-page":"784616","DOI":"10.3389\/fendo.2021.784616","volume":"12","author":"S Zou","year":"2021","unstructured":"Zou S, Yang C, Shen R, Wei X, Gong J, Pan Y, et al. Association between the triglyceride-glucose index and the incidence of diabetes. Front Endocrinol. 2021;12:784616.","journal-title":"Front Endocrinol"},{"key":"2375_CR35","doi-asserted-by":"publisher","first-page":"108533","DOI":"10.1016\/j.diabres.2020.108533","volume":"171","author":"JA Kim","year":"2021","unstructured":"Kim JA, Kim J, Roh E, Hong SH, Lee YB, Baik SH, et al. Triglyceride and glucose index and the risk of gestational diabetes mellitus. Diabetes Res Clin Pract. 2021;171:108533.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2375_CR36","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s12967-023-04402-1","volume":"21","author":"X Chen","year":"2023","unstructured":"Chen X, Liu D, He W, Hu H, Wang W. Predictive performance of triglyceride glucose index (TyG index) to identify glucose status conversion. J Transl Med. 2023;21(1):624.","journal-title":"J Transl Med"},{"issue":"06","key":"2375_CR37","first-page":"484","volume":"15","author":"Chinese Society of Endocrinology, Chinese Diabetes Society, Chinese Endocrinologist Association","year":"2023","unstructured":"Chinese Society of Endocrinology, Chinese Diabetes Society, Chinese Endocrinologist Association. Intervention for adults with pre-diabetes: a Chinese expert consensus. Chin J Diabetes. 2023;15(06):484\u201394.","journal-title":"Chin J Diabetes"},{"key":"2375_CR38","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.2147\/DMSO.S341285","volume":"14","author":"G Xie","year":"2021","unstructured":"Xie G, Zhong Y, Yang S, Zou Y. Remnant cholesterol is an independent predictor of New-Onset diabetes. Diabetes Metab Syndr Obes. 2021;14:4735\u201345.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"2375_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12933-024-02163-9","volume":"23","author":"X Wu","year":"2024","unstructured":"Wu X, Qiu W, Yang H, Chen YJ, Liu J, Zhao G. Associations of the triglyceride-glucose index and atherogenic index of plasma with the severity of new-onset coronary artery disease. Cardiovasc Diabetol. 2024;23(1):76.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-024-02375-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-024-02375-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-024-02375-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T08:18:29Z","timestamp":1732781909000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-024-02375-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2375"],"URL":"https:\/\/doi.org\/10.1186\/s12944-024-02375-8","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"18 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The CHARLS study was approved by the Institutional Review Board of Peking University. All participants provided written informed consent before participating in the CHARLS study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"394"}}